AMENDMENT TO INTERIM CHIEF OPERATING OFFICER AGREEMENTInterim Chief Operating Officer Agreement • April 16th, 2015 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances)
THIS AMENDMENT TO INTERIM CHIEF OPERATING OFFICER AGREEMENT (this “Amendment”), is made this 15th day of January, 2015 (the “Effective Date”), by and among AmpliPhi Biosciences, a Washington corporation (the “Company”) and Wendy S. Johnson (the “Consultant”).
